ARCHIVES

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

This article is from The Cancer Letter archive.

Vol. 19 No. 40 | October 15, 1993

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

National Cancer Act: Early Promises Were Overstated

May 15, 1998

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.

May 27, 2005

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978